Ruolan Li

2.4k total citations · 2 hit papers
67 papers, 1.8k citations indexed

About

Ruolan Li is a scholar working on Molecular Biology, Plant Science and Complementary and alternative medicine. According to data from OpenAlex, Ruolan Li has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Plant Science and 9 papers in Complementary and alternative medicine. Recurrent topics in Ruolan Li's work include Atherosclerosis and Cardiovascular Diseases (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Ruolan Li is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (5 papers), Rheumatoid Arthritis Research and Therapies (5 papers) and Medicinal Plants and Neuroprotection (4 papers). Ruolan Li collaborates with scholars based in China, United States and France. Ruolan Li's co-authors include Chunjie Wu, Wei Peng, Qing Zhang, Huxinyue Duan, Jia Liu, Shujun Wei, Yongxiang Gao, Jia Liu, Dan Wang and Mengmeng Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Applied Catalysis B: Environmental and Chemical Engineering Journal.

In The Last Decade

Ruolan Li

59 papers receiving 1.8k citations

Hit Papers

Activation of Nrf2/HO-1 signaling: An important molecular... 2021 2026 2022 2024 2021 2021 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruolan Li China 20 883 257 247 203 197 67 1.8k
Kailin Yang China 26 757 0.9× 204 0.8× 278 1.1× 210 1.0× 193 1.0× 103 2.1k
Nehal M. Elsherbiny Egypt 36 1.2k 1.3× 331 1.3× 237 1.0× 218 1.1× 257 1.3× 114 3.2k
Longhuo Wu China 24 1.0k 1.1× 175 0.7× 173 0.7× 236 1.2× 212 1.1× 54 1.9k
Shuai Wang China 27 1.1k 1.2× 347 1.4× 230 0.9× 150 0.7× 289 1.5× 145 2.2k
Xu Han China 27 971 1.1× 379 1.5× 170 0.7× 254 1.3× 228 1.2× 53 2.3k
Syed Shadab Raza India 31 1.0k 1.2× 165 0.6× 352 1.4× 182 0.9× 219 1.1× 78 2.9k
Weixing Shen China 24 865 1.0× 168 0.7× 252 1.0× 191 0.9× 207 1.1× 94 1.7k
Ruyuan Zhu China 23 965 1.1× 242 0.9× 306 1.2× 135 0.7× 107 0.5× 46 1.9k
Somasundaram Arumugam Japan 32 1.0k 1.1× 249 1.0× 179 0.7× 323 1.6× 133 0.7× 86 2.8k

Countries citing papers authored by Ruolan Li

Since Specialization
Citations

This map shows the geographic impact of Ruolan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolan Li more than expected).

Fields of papers citing papers by Ruolan Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruolan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolan Li. The network helps show where Ruolan Li may publish in the future.

Co-authorship network of co-authors of Ruolan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Ruolan Li. A scholar is included among the top collaborators of Ruolan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruolan Li. Ruolan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Wei, Tianqiu Hong, Qiang Zhang, et al.. (2025). Exploring the effect of low-temperature thermal-alkaline pretreatment on struvite recovery from metals-phosphorus rich sludge. Journal of environmental chemical engineering. 13(2). 115803–115803. 3 indexed citations
2.
Zhao, Xingtao, et al.. (2025). Targeting the gut microbiota-bile acid axis: Therapeutic strategies for cholestatic liver disease and metabolic dysfunction-associated steatotic liver disease. SHILAP Revista de lepidopterología. 2(3). 100088–100088. 1 indexed citations
3.
Lu, Hong‐Yan, Xiong-ming Pu, Xingtao Zhao, et al.. (2025). Nanozyme-mediated drug ion-exchange strategy ameliorates inflammatory bowel disease by scavenging ROS and reprogramming proinflammatory macrophages. Chemical Engineering Journal. 525. 170265–170265.
6.
Banerjee, Shubhasree, Naomi A. Amudala, Sherry Chou, et al.. (2024). Patient‐Reported Sinonasal Symptoms and Risk of Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis. Arthritis Care & Research. 76(8). 1099–1108.
7.
Tan, Ya, Yue Cheng, Mei Yang, et al.. (2024). Dronedarone hydrochloride (DH) induces pancreatic cancer cell death by triggering mtDNA-mediated pyroptosis. Cell Death and Disease. 15(10). 725–725. 5 indexed citations
8.
Hong, Tianqiu, Wei Lin, Ziyue Li, et al.. (2023). Exploring the acid–base surface properties of vivianite crystals in aqueous solution. Surface and Interface Analysis. 55(12). 871–879. 2 indexed citations
9.
Li, Ruolan, Ling‐Yu Wang, Huxinyue Duan, et al.. (2023). Natural flavonoids derived from herbal medicines are potential anti-atherogenic agents by inhibiting oxidative stress in endothelial cells. Frontiers in Pharmacology. 14. 1141180–1141180. 10 indexed citations
10.
Duan, Huxinyue, et al.. (2023). Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines. Frontiers in Pharmacology. 14. 1161657–1161657. 14 indexed citations
11.
Li, Ruolan, Feng Lü, Liying He, et al.. (2022). Development and in vivo Evaluation of Hydroxy-α-Sanshool Intranasal Liposomes as a Potential Remedial Treatment for Alzheimer’s Disease. Dove Medical Press (Taylor and Francis Group). 22 indexed citations
13.
Li, Ruolan, Lingyu Wang, Qing Zhang, et al.. (2022). Alpiniae oxyphyllae fructus possesses neuroprotective effects on H2O2 stimulated PC12 cells via regulation of the PI3K/Akt signaling Pathway. Frontiers in Pharmacology. 13. 966348–966348. 19 indexed citations
14.
Li, Ruolan, Huxinyue Duan, Yong‐Liang Huang, et al.. (2022). Targeting matrix metalloproteases: A promising strategy for herbal medicines to treat rheumatoid arthritis. Frontiers in Immunology. 13. 1046810–1046810. 25 indexed citations
15.
Li, Ruolan, Ling‐Yu Wang, Huxinyue Duan, et al.. (2022). Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases. Frontiers in Pharmacology. 13. 937289–937289. 26 indexed citations
16.
Zhu, Tianhui, Yan Fu, Ruolan Li, et al.. (2021). New protein tyrosine phosphatase inhibitors from fungus Aspergillus gorakhpurensis F07ZB1707. RSC Advances. 11(17). 10144–10153. 6 indexed citations
17.
Duan, Huxinyue, Ruolan Li, Jiayi Sun, et al.. (2021). Inducing Apoptosis and Suppressing Inflammatory Reactions in Synovial Fibroblasts are Two Important Ways for Guizhi-Shaoyao-Zhimu Decoction Against Rheumatoid Arthritis. Journal of Inflammation Research. Volume 14. 217–236. 18 indexed citations
18.
Zhang, Qing, Ruolan Li, Jiayi Sun, et al.. (2021). Antiepileptic Effects of Cicadae Periostracum on Mice and Its Antiapoptotic Effects in H2O2‐Stimulated PC12 Cells via Regulation of PI3K/Akt/Nrf2 Signaling Pathways. Oxidative Medicine and Cellular Longevity. 2021(1). 5598818–5598818. 12 indexed citations
19.
Li, Ruolan, et al.. (2020). Input matters in the modeling of early phonetic learning. Cognitive Science. 1 indexed citations
20.
Zhang, Qing, Jia Liu, Ruolan Li, et al.. (2020). A Network Pharmacology Approach to Investigate the Anticancer Mechanism and Potential Active Ingredients of Rheum palmatum L. Against Lung Cancer via Induction of Apoptosis. Frontiers in Pharmacology. 11. 528308–528308. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026